Publication: Combining Xenon Inhalation With Trauma Memory Reactivation to Reduce Symptoms of Posttraumatic Stress Disorder
No Thumbnail Available
Open/View Files
Date
2019-09-19
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Physicians Postgraduate Press, Inc
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Dobrovolsky, Alexander, Vladimir Bogin, and Edward G. Meloni. 2019. Combining Xenon Inhalation With Trauma Memory Reactivation to Reduce Symptoms of Posttraumatic Stress Disorder: Case Report, Justification of Approach, and Review of the Literature. The Primary Care Companion for CNS Disorders 21, no. 5.
Research Data
Abstract
Posttraumatic stress disorder (PTSD) is a debilitating disease with limited available treatment options and for which novel effective interventions constitute a significant unmet need. This case report describes successful treatment of a patient with panic disorder and PTSD stemming from the 2010 Moscow subway terrorist attacks through the combination of script-driven trauma memory reactivation and inhalation of a xenon-based gas mixture. Xenon is a competitive inhibitor of N-methyl-d-aspartate receptors known to play a role in memory reconsolidation, a learning and memory process wherein memories temporarily enter a labile state after reactivation and may be modified. Literature describing current pharmacologic and exposure-based treatments is reviewed and provides the basis for use of this novel treatment strategy to target and modify emotional memories.
Description
Physicians Postgraduate Press, Inc., publisher of The Journal of Clinical Psychiatry and The Primary Care Companion for CNS Disorders, must retain exclusive and unfettered copyright of published materials either in print or electronic formats in perpetuity. If, after peer review, you are invited by the editor to revise your manuscript, any author or coauthor affiliated with an institution that requires open access to published manuscripts must submit (1) a copy of the institution's policy and (2) an acknowledgment from the institution that it has received an opt-out, waiver, or other official document signed by the author and the authorized designate from the institution. The opt-out, waiver, or other official document must represent the express direction of the author that the institution relinquishes any and all explicit or implicit rights of the institution to publish or house the manuscript in any form. The publisher's copyright protection lasts the life of the author plus an additional seventy (70) years.:
One author or more is affiliated with an institution that carries an open access policy.
List all authors and their respective institutions with an open access policy:
Edward Meloni
Other Available Sources
Keywords
Terms of Use
Metadata Only